Original Research

Published on 02 Dec 2022

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma

in Pharmacology of Anti-Cancer Drugs

Jian Huang
Wang Liu
Shiqi Song
Jean C. Li
Kaimei Gan
Chunxiao Shen
Jeffrey Holzbeierlein
Benyi Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1080055

2,706 views
2 citations

Original Research

Published on 02 Dec 2022

The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells

in Pharmacology of Anti-Cancer Drugs

Miso Park
Seung Hyun Lee
Quyen Thu Bui
Young-Mi Kim
Keon Wook Kang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1057276

2,135 views
1 citation

Systematic Review

Published on 02 Dec 2022

Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Yingjie Qi
Xin Yan
Chao Wang
Hui Cao
Guangxuan Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1004821

1,723 views
3 citations

Original Research

Published on 01 Dec 2022

MM/PB(GB)SA benchmarks on soluble proteins and membrane proteins

in Pharmacology of Anti-Cancer Drugs

Shiyu Wang
Xiaolin Sun
Wenqiang Cui
Shuguang Yuan

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1018351

2,726 views
3 citations

Review

Published on 01 Dec 2022

Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review

in Pharmacology of Anti-Cancer Drugs

Shuang Luo
Yu Jiang
Anfu Zheng
Yueshui Zhao
Xu Wu
Mingxing Li
Fukuan Du
Yu Chen
Shuai Deng
Meijuan Chen

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1064661

2,563 views
5 citations

Review

Published on 01 Dec 2022

Non-coding RNA-related antitumor mechanisms of marine-derived agents

in Pharmacology of Anti-Cancer Drugs

Zhixia Zhou
Qianqian Cao
Yujing Diao
Yin Wang
Linhai Long
Shoushi Wang
Peifeng Li

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053556

752 views
2 citations

Systematic Review

Published on 01 Dec 2022

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin’s lymphoma: A systematic review and meta-analysis

in Pharmacology of Anti-Cancer Drugs

Bin Lu
Longfei Shen
Ying Ma
Jia Qi
Yulin Li
Zhihao Wang
Lu Han
Ming Zhong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1060668

2,227 views

Original Research

Published on 01 Dec 2022

A novel biflavone from Reineckia carnea induces apoptosis of human renal cancer 786-O cells

in Pharmacology of Anti-Cancer Drugs

Jianqiong Yang
Bang Xiao
Yamei Li
Xiaoxuan Liu
Minhong Zhang
Yaoling Luo
Biao Wang
Hai Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1053184

1,382 views
2 citations

Original Research

Published on 01 Dec 2022

The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo

in Pharmacology of Anti-Cancer Drugs

Sara Vaccaro
Alessandra Rossetti
Antonella Porrazzo
Simona Camero
Matteo Cassandri
Silvia Pomella
Miriam Tomaciello
Giampiero Macioce
Francesca Pedini
Giovanni Barillari

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1071176

2,438 views

Original Research

Published on 30 Nov 2022

Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression

in Pharmacology of Anti-Cancer Drugs

Xianqiang Luo
Guohui Wang
Yuting Wang
Meichen Wang
Zhuomin Tan
Min Luo
Limei Zhang
Yan Song
Yinnong Jia
Hongyu Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1059365

1,282 views
1 citation

Original Research

Published on 30 Nov 2022

Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer

in Pharmacology of Anti-Cancer Drugs

Qiang Wang
Yue Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1065701

2,371 views
4 citations

Editorial

Published on 30 Nov 2022

Editorial: Women in pharmacology of anti-cancer drugs: 2021

in Pharmacology of Anti-Cancer Drugs

Elisa Giovannetti

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1092204

752 views

Review

Published on 30 Nov 2022

Targeting glycolysis in non-small cell lung cancer: Promises and challenges

in Pharmacology of Anti-Cancer Drugs

Jia-Qi Xu
Yan-Li Fu
Jing Zhang
Kai-Yu Zhang
Jie Ma
Jing-Yi Tang
Zhi-Wei Zhang
Zhong-Yan Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1037341

4,305 views
6 citations

Original Research

Published on 30 Nov 2022

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling

in Pharmacology of Anti-Cancer Drugs

Jiayun Xu
Shanshan Sun
Wei Zhang
Jianhong Dong
Changgang Huang
Xin Wang
Mengxian Jia
Hao Yang
Yongjie Wang
Yuanyuan Jiang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1027577

2,083 views
1 citation

Original Research

Published on 29 Nov 2022

Feiyanning formula modulates the molecular mechanism of osimertinib resistance in lung cancer by regulating the Wnt/β-catenin pathway

in Pharmacology of Anti-Cancer Drugs

Shuliu Sang
Chenbing Sun
Rongzhen Ding
Jingjie Jiang
Yang Han
Shanshan Gan
Ling Bi
Yabin Gong

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1019451

1,964 views
1 citation

Original Research

Published on 29 Nov 2022

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways

in Pharmacology of Anti-Cancer Drugs

Si Lin
Hui-Zhen Qin
Ze-Yu Li
Hua Zhu
Li Long
Li-Ba Xu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.1049117

1,990 views
1 citation

Navigation group

Articles

The iron-modulating hormone hepcidin is upregulated and associated with poor survival outcomes in renal clear cell carcinoma

The essential role of YAP in ERα36-mediated proliferation and the epithelial-mesenchymal transition in MCF-7 breast cancer cells

Predictive value of PD-L1 expression to the efficacy of immune checkpoint inhibitors in advanced triple-negative breast cancer: A systematic review and meta-analysis

MM/PB(GB)SA benchmarks on soluble proteins and membrane proteins

Targeting hypoxia-inducible factors for breast cancer therapy: A narrative review

Non-coding RNA-related antitumor mechanisms of marine-derived agents

Cardiovascular adverse events associated with cyclophosphamide, pegylated liposomal doxorubicin, vincristine, and prednisone with or without rituximab ((R)-CDOP) in non-Hodgkin’s lymphoma: A systematic review and meta-analysis

A novel biflavone from Reineckia carnea induces apoptosis of human renal cancer 786-O cells

The botanical drug PBI-05204, a supercritical CO2 extract of Nerium oleander, sensitizes alveolar and embryonal rhabdomyosarcoma to radiotherapy in vitro and in vivo

Gibberellin derivative GA-13315 overcomes multidrug resistance in breast cancer by up-regulating BMP6 expression

Comprehensive analysis of cuproptosis-related lncRNAs model in tumor immune microenvironment and prognostic value of cervical cancer

Editorial: Women in pharmacology of anti-cancer drugs: 2021

Targeting glycolysis in non-small cell lung cancer: Promises and challenges

Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling

Feiyanning formula modulates the molecular mechanism of osimertinib resistance in lung cancer by regulating the Wnt/β-catenin pathway

Gallic acid suppresses the progression of triple-negative breast cancer HCC1806 cells via modulating PI3K/AKT/EGFR and MAPK signaling pathways